Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles E Alpers

Showing results (11-20 of 267) with videos related to

Pageof 27
Sort By:
Current Opinion in Nephrology and Hypertension|June 3, 2005
Pathogenic mechanisms in membranoproliferative glomerulonephritisKelly D Smith, Charles E Alpers
Kidney Research and Clinical Practice|July 5, 2018
Pathology identifies glomerular treatment targets in diabetic nephropathyCharles E Alpers, Kelly L Hudkins
Nature Reviews. Nephrology|September 25, 2009
Diagnosis: should renal biopsies be performed in the very elderly?J Ashley Jefferson, Charles E Alpers
Current Opinion in Nephrology and Hypertension|March 23, 2011
Mouse models of diabetic nephropathyCharles E Alpers, Kelly L Hudkins
Nature Reviews. Nephrology|December 14, 2011
Glomerular disease in 2011: New clues to environmental influences in glomerular diseasePeter J Nelson, Charles E Alpers
Journal of the American Society of Nephrology : JASN|December 4, 2010
Navigating the challenges of fibrosis assessment: land in sight?Agnes B Fogo, Charles E Alpers
Current Opinion in Nephrology and Hypertension|December 5, 2012
New targets for treatment of diabetic nephropathy: what we have learned from animal modelsFrank C Brosius, Charles E Alpers
Journal of the American Society of Nephrology : JASN|December 14, 2007
A new look at platelet-derived growth factor in renal diseaseJürgen Floege, Frank Eitner, Charles E Alpers
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 5, 2003
Crystals in podocytes: an unusual manifestation of systemic diseaseJolanta Kowalewska, Robert C Tomford, Charles E Alpers
Contributions to Nephrology|June 11, 2011
Pathology of human diabetic nephropathyBehzad Najafian, Charles E Alpers, Agnes B Fogo
Pageof 27

Showing results (11-20 of 267) with videos related to

Sort By:
Pageof 27
Current Opinion in Nephrology and Hypertension|June 3, 2005
Pathogenic mechanisms in membranoproliferative glomerulonephritisKelly D Smith, Charles E Alpers
Kidney Research and Clinical Practice|July 5, 2018
Pathology identifies glomerular treatment targets in diabetic nephropathyCharles E Alpers, Kelly L Hudkins
Nature Reviews. Nephrology|September 25, 2009
Diagnosis: should renal biopsies be performed in the very elderly?J Ashley Jefferson, Charles E Alpers
Current Opinion in Nephrology and Hypertension|March 23, 2011
Mouse models of diabetic nephropathyCharles E Alpers, Kelly L Hudkins
Nature Reviews. Nephrology|December 14, 2011
Glomerular disease in 2011: New clues to environmental influences in glomerular diseasePeter J Nelson, Charles E Alpers
Journal of the American Society of Nephrology : JASN|December 4, 2010
Navigating the challenges of fibrosis assessment: land in sight?Agnes B Fogo, Charles E Alpers
Current Opinion in Nephrology and Hypertension|December 5, 2012
New targets for treatment of diabetic nephropathy: what we have learned from animal modelsFrank C Brosius, Charles E Alpers
Journal of the American Society of Nephrology : JASN|December 14, 2007
A new look at platelet-derived growth factor in renal diseaseJürgen Floege, Frank Eitner, Charles E Alpers
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 5, 2003
Crystals in podocytes: an unusual manifestation of systemic diseaseJolanta Kowalewska, Robert C Tomford, Charles E Alpers
Contributions to Nephrology|June 11, 2011
Pathology of human diabetic nephropathyBehzad Najafian, Charles E Alpers, Agnes B Fogo
Pageof 27